• Explore /
  • Poster
  • / Thoracic radiotherapy PLUS durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy: Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy—The TRADE-hypo trial.

Thoracic radiotherapy PLUS durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy: Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy—The TRADE-hypo trial.

Abstract Video & Slides Poster

Authors

null

Farastuk Bozorgmehr

Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany

Farastuk Bozorgmehr , Jessica Juergens , Michaela Hammer-Hellmig , Christian Meyer Zum Bueschenfelde , Johannes Classen , Juergen Alt , Marcus Stockinger , Matthias Ulmer , Arndt-Christian Müller , Philipp Schütt , Michael J. Eble , Juergen R. Fischer , Christian A. Lerchenmuller , Tobias R. Overbeck , Henning Pelz , Bernd Schmidt , Thomas Wehler , Johannes Krisam , Stefan Rieken , Michael Thomas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04351256

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS8585)

DOI

10.1200/JCO.2021.39.15_suppl.TPS8585

Abstract #

TPS8585

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ethan Burns

First Author: Howard Jinsoo Lee Jr.

First Author: Nikhil Yegya-Raman

First Author: Malcolm Isaiah Ryan